Submit Deal

AVIDITY PARTNERS

HQ - Dallas, TX

Summary

Avidity Partners is an investment management firm that offers financial services.

Deals Overview

Total Deals34

Valued Deals33

Total Value£ 6.61 B

Avg. Deal Size£ 200 M

Market Context

Senior Management

Jill Ross
CEO
Michael Gregory
Managing Partner
David Witzke
Managing Partner

Sort

shattuck labs

HQ - United States

Biotechnology

15 Jun 2020

Investment Date

£ 94 M

Deal Value

neurogene inc

HQ - United States

Biotechnology

16 Dec 2020

Investment Date

£ 85 M

Deal Value

century therapeutics

HQ - United States

Biotechnology

3 Mar 2021

Investment Date

£ 115 M

Deal Value

crossover health

HQ - United States

Medical Services

29 Mar 2021

Investment Date

£ 121 M

Deal Value

affinia therapeutics

HQ - United States

Biotechnology

3 May 2021

Investment Date

£ 80 M

Deal Value

hyperfine research inc

HQ - United States

Software

22 Dec 2021

Investment Date

100%

Stake

£ 420 M

Deal Value

artios pharma limited

HQ - United Kingdom

Biotechnology

27 Jul 2021

Investment Date

£ 110 M

Deal Value

exo

HQ - United States

Medical Equipment

29 Jul 2021

Investment Date

£ 158 M

Deal Value

eqrx

HQ - United States

Pharmaceuticals

2 Dec 2021

Investment Date

100%

Stake

£ 2.62 B

Deal Value

gentibio

HQ - United States

Biotechnology

11 Aug 2021

Investment Date

£ 113 M

Deal Value

neogenomics

HQ - United States

Health Care Facilities

5 May 2021

Investment Date

Stake

£ 144 M

Deal Value

elemy

HQ - United Kingdom

Health Care Services

6 Oct 2021

Investment Date

£ 160 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy